Updated on 20 June 2014
With an FDA nod, the Holly spring's facility will now make vaccines for seasonal influenza
Singapore: The Holly spring's facility in the US that was previously authorised only to make emergency vaccine for flu pandemics, will now make vaccines for seasonal influenza.
The company said be it will be the first US facility to make commercial supplies of flu vaccine from cell cultures instead of chicken eggs. Using cell cultures to make flu vaccine is considered advantageous because production time is reduced from several months to a few weeks, the company explained. It added that it is not dependent on eggs from chickens that could be wiped out by avian flu.
About half the funding for the 430,000-square feet facility came from the US Department of Health and Human Services and the Biomedical Advanced Research and Development Authority (BARDA). The federal government has backed the project as part of the nation's public safety program against potentially fatal flu outbreaks.
The facility employs about 800 scientists and others and was built with more than $40 million in state and local incentives, including land, roads and other infrastructure provided by the town of Holly Springs.